Building a new generation of microbiological technologies
Spore.Bio has raised €30M across 3 funding rounds from 9 investors, most recently a round in Jan 2026. Based in Paris, France; active in AI. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-08 | Other | — | Google.Org Fund for AI in Science | View deal → |
| 2025-02-20 | Series A | €22M | 1st Kind Ventures,Existing investors,Famille C Venture,LocalGlobe,Lord David Prior,No Label Ventures+2 more | View deal → |
| 2023-12-12 | Pre-Seed | €8.0M | LocalGlobe | View deal → |
